贵春山，男，副教授，获得2007年度美国堪萨斯大学医学中心生物医学基金。至今已发表学术论文23篇，其中SCI收录论文22篇。申请专利2项。兼任国际刊物《European Journal of Pharmacology》、《Journal of Pharmacy & Pharmaceutical Sciences》和《Pharmacology》的审稿人。1996－2000 ，获理学学士学位2000－2005 上海药物研究所，获理学博士学位2005－2010 美国堪萨斯大学医学中心，博士后2011－ 苏州大学医学部药学院，副教授
2008 获美国药理学和实验治疗学会（ASPET）博士后年青科学家奖2010 获欧洲药理学杂志论文最高引用奖
1) Gui C, Obaidat A, Chaguturu R, Hagenbuch B. Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr. Chem. Genomics 2010, 4:1-8.2) Gui C, Hagenbuch B. Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO members. Comp. Biochem. Physiol. 2010, 151:393-399.3) Gui C, Hagenbuch B. Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Sci. 2009, 18:2298-2306.4) Gui C, Wahlgren B, Lushington GH, Hagenbuch B. Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17β-glucuronide transport. Pharmacol. Res. 2009, 60:50-56.5) Gui C, Hagenbuch B. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. Biochemistry 2008, 47:9090-9097.6) Gui C, Miao Y, Thompson L, Wahlgren B, Mock M, Stieger B, Hagenbuch B. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur. J. Pharmacol. 2008, 584:57-65.7) B. Hagenbuch, C. Gui. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008, 38:778-801.8) Gui C, Zhu W, Chen G, Luo X, Liew OW, Puah CM, Shen J, et al. Understanding the regulation mechanisms of PAF receptor by agonists and antagonists: molecular modeling and molecular dynamics simulation studies. Proteins 2007, 67:41-52.9) Chen L, Gui C, Luo X, Yang Q, Günther S, Scandella E, Drosten C, et al. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 2005, 79:7095-7103.10) 贵春山，沈建华，罗小民，朱维良，沈旭，蒋华良. 雌激素受体和选择性雌激素受体调节剂的研究进展. 中国药物化学杂志 2005, 15:313-320.
苏州大学药学院四川大学中科院   